BridgeMD
Compares treatment options for Lumbar Radiculopathy
Official title R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery
ClinicalTrials.gov ID: NCT07313566
What this study is testing
- What it's testing
- The R³ trial is a multicentre cluster randomized controlled trial evaluating an evidence-based, person-centred rehabilitation pathway for patients undergoing lumbar surgery for radicular pain. The pathway includes structured pre-, peri-, and postoperative rehabilitation, early postoperative mobilization, case management, early return-to-work (RTW) guidance, and patient empowerment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Radicular pain (for ≥ 6 weeks prior to screening), with a clear indication for lumbar spinal surgery ((micro)discectomy, decompression and/or...
- Employed (working or on sick leave for less than 1 year due to spinal pathology)
- Age 18 - 65 years
- Surgery is scheduled within a timeframe of five days to 2 months after the decision for surgery (4 months for fusion)
- For lumbar fusion surgery, the fusion should be restricted to one or two levels
You likely can't join if
- Patients are not eligible for the trial in case of any of the following criteria:
- Lumbar surgery performed for malignant disease, spinal fracture, infectious spinal disease
- Insufficient knowledge of Dutch or French language to receive education in the recruiting center and to complete the questionnaires (consistent with...
- Immediate surgery via emergency admission that precludes prehabilitation
- Revision fusion surgery
- Non-residency in Belgium
See the full eligibility criteria
- Radicular pain (for ≥ 6 weeks prior to screening), with a clear indication for lumbar spinal surgery ((micro)discectomy, decompression and/or fusion), in accordance with the KCE guidelines (when evidence-based...
- Employed (working or on sick leave for less than 1 year due to spinal pathology)
- Age 18 - 65 years
- Surgery is scheduled within a timeframe of five days to 2 months after the decision for surgery (4 months for fusion)
- For lumbar fusion surgery, the fusion should be restricted to one or two levels
- Able to provide written informed consent, implying that the participant is both physically and cognitively capable of understanding the study information and signing the consent form independently.
- Patients are not eligible for the trial in case of any of the following criteria:
- Lumbar surgery performed for malignant disease, spinal fracture, infectious spinal disease
- Insufficient knowledge of Dutch or French language to receive education in the recruiting center and to complete the questionnaires (consistent with the language spoken in the recruiting centre)
- Immediate surgery via emergency admission that precludes prehabilitation
- Revision fusion surgery
- Non-residency in Belgium
The study team makes the final eligibility decision.
Where it's taking place
- Antwerp, Belgium
- Bruges, Belgium
- Brussels, Belgium
- Charleroi, Belgium
- Geel, Belgium
- Genk, Belgium
- Hasselt, Belgium
- Herentals, Belgium
- Ieper, Belgium
- Kortrijk, Belgium
- Leuven, Belgium
- Lier, Belgium
- Mechelen, Belgium
- Ottignies, Belgium
- Roeselare, Belgium
- Tournai, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Antwerp, Belgium; Bruges, Belgium; Brussels, Belgium; Charleroi, Belgium; Geel, Belgium; Genk, Belgium and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.